A Study of the Efficacy and Safety of Apremilast (CC-10004) in Subjects With Moderate to Severe Plaque Psoriasis of the Scalp

NCT03123471 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

303

Enrollment

INDUSTRY

Sponsor class

Conditions

Psoriasis

Interventions

DRUG: Apremilast
OTHER: Placebo

Sponsor

Amgen